4.40MMarket Cap-100P/E (TTM)
0.6600High0.6350Low77.24KVolume0.6400Open0.6399Pre Close49.49KTurnover1.25%Turnover RatioLossP/E (Static)6.88MShares5.239952wk High0.36P/B3.97MFloat Cap0.602052wk Low--Dividend TTM6.20MShs Float59.5990Historical High--Div YieldTTM3.91%Amplitude0.6020Historical Low0.6400Avg Price1Lot Size
Petros Pharmaceuticals Stock Forum
Update
NEWS
Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
News
4 MINUTES AGO, 9:15 AM EDT
VIA ACCESSWIRE
Pharmaceuticals Company Reports Positive Results For ED Study
Petros Pharmaceuticals has shared positive outcomes from a crucial Phase 2-equivalent study for STENDRA(R) (avanafil), marking a significant milestone in the medication's journey towards over-the-counter (OTC) availability. This innovative study paves the way for enhancing accessibility to treatment options for erectile dysfunction (ED), p...
Update
Accesswire· 5 mins ago
No comment yet